Malden, MA, United States of America

Leonid A Gaydukov

This inventor holds 1 USPTO granted patent. Top assignee: Codiak Biosciences, Inc.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leonid A Gaydukov. Retrieved from https://idiyas.com/inventor/leonid-a-gaydukov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Leonid A. Gaydukov: Innovator in Immuno-Oncology

Introduction

Leonid A. Gaydukov is a prominent inventor based in Malden, MA (US). He has made significant contributions to the field of immuno-oncology and anti-inflammatory therapy. His innovative work focuses on the use of extracellular vesicles for therapeutic applications.

Latest Patents

Leonid A. Gaydukov holds a patent for "Exosomes for immuno-oncology and anti-inflammatory therapy." This patent discloses extracellular vesicles comprising an immunomodulating component. It also provides methods for producing these extracellular vesicles and outlines their use in treating cancer, graft-versus-host disease (GvHD), and autoimmune diseases. He has 1 patent to his name.

Career Highlights

Leonid is currently associated with Codiak Biosciences, Inc., where he continues to advance research in the field of immunotherapy. His work is pivotal in developing new treatment modalities that leverage the body's immune system to combat diseases.

Collaborations

He collaborates with notable colleagues, including Ke Xu and Sriram Sathyanarayanan, to further enhance the impact of their research in the biomedical field.

Conclusion

Leonid A. Gaydukov's innovative contributions to immuno-oncology exemplify the potential of extracellular vesicles in modern medicine. His work continues to pave the way for new therapeutic strategies in treating complex diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…